New York College of Podiatric Medicine

Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023

Retrieved on: 
Monday, September 18, 2023
KOL, U.S. Department of Defense Strategy for Operating in Cyberspace, Defense, Regenerative medicine, HUMA, New York College of Podiatric Medicine, New Jersey Medical School, MPA, HAV, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Injury, Pharmaceutical industry, MD

DURHAM, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced it will host an in-person KOL event on Wednesday, September 20, 2023 at 3:00pm ET at The New York EDITION Hotel.

Key Points: 
  • DURHAM, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, announced it will host an in-person KOL event on Wednesday, September 20, 2023 at 3:00pm ET at The New York EDITION Hotel.
  • The event will feature Michael Curi, MD, MPA (Rutgers New Jersey Medical School) and his patient Devin Barnett, who will discuss the recently announced top line clinical data from the Humacyte Phase 2/3 V005 vascular trauma trial, the unmet clinical need in treating these injuries, and the use of the Human Acellular Vessel™ (HAV™) in repairing blood vessels.
  • The HAV is an off-the-shelf, universally implantable bioengineered human tissue, that is being studied in traumatic vascular injury and other vascular diseases.
  • The HAV has received priority designation for the treatment of vascular trauma by the U.S. Department of Defense and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration.

Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer

Retrieved on: 
Wednesday, February 22, 2023
Boston University, Master of Business Administration, New York College of Podiatric Medicine, Podiatry, Acquisition, Interim, Skin, Lead, Business administration, Subcutaneous tissue, College, Knowledge, Economics, Chairperson, College of the Holy Cross, Growth, Holy Cross, Humanities, History, Management

Mr. Bitterman has served as Interim Chief Executive Officer since September 2022.

Key Points: 
  • Mr. Bitterman has served as Interim Chief Executive Officer since September 2022.
  • Mr. Bitterman will continue to serve as Chair of the Board, and as the Company's principal executive officer and principal financial officer.
  • "As we considered the next chapter for Phio, the Board undertook a thorough search for a full-time CEO," said Robert Ferrara, Phio's Lead Independent Director.
  • Prior to his role at Cutanea Life Sciences, Inc., Mr. Bitterman held the position of President and Chief Executive Officer of Isolagen, Inc., President and General Manager of Dermik Laboratories, and various positions of increasing responsibility in financial and commercial capacities within Aventis S.A. Mr. Bitterman holds an A.B.

New Jersey Podiatrist Teams with Ankle & Foot Centers of America

Retrieved on: 
Tuesday, November 1, 2022
Foot and ankle surgery, Clubfoot, Podiatry, Foot, GLOBE, Industry, Physician, Bunion, Deformity, Technology, Trauma, Patient, Podiatrist, New York College of Podiatric Medicine, Practice management, DPM, Medicine, Medical device, Ankle

WAYNE, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Renown New Jersey podiatrist Lindsey Calligaro, DPM, of Wayne Foot & Ankle Center has recently teamed with Ankle & Foot Centers of America, the market leader in physician practice management and process improvement, to better serve patients.

Key Points: 
  • WAYNE, N.J., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Renown New Jersey podiatrist Lindsey Calligaro, DPM, of Wayne Foot & Ankle Center has recently teamed with Ankle & Foot Centers of America, the market leader in physician practice management and process improvement, to better serve patients.
  • Teaming with Ankle & Foot Centers of America allows physicians like Dr. Calligaro to do what they do best, take care of patients.
  • With a shared commitment to excellence and dedication to patient well-being, Dr. Calligaro and the team at Ankle and Foot Centers of America look forward to treating the foot and ankle needs of patients in north New Jersey.
  • About Ankle & Foot Centers of America - Founded in Atlanta over 30 years ago, Ankle & Foot Centers of America is dedicated to providing patients with top-tier service and support through best-in-class technology and processes so that physicians can optimize patient outcomes and satisfaction.

Triple Board Certified Ankle & Foot Surgeon, Dr. Humaira Syed Named NJ Top Doc

Retrieved on: 
Friday, October 29, 2021
Kindred Hospital - San Francisco Bay Area, New York College of Podiatric Medicine, American College of Foot and Ankle Surgeons, Pathology, Patient, Ankle, Fort Lee, Adult, Mount Sinai Hospital, Dentist, American College, Mount Sinai Hospital (Manhattan), American Podiatric Medical Association, American Board of Commissioners for Foreign Missions, Psychology, Physician, Dentistry, Medicine, Medical device

SCOTCH PLAINS, N.J., Oct. 29, 2021 /PRNewswire-PRWeb/ -- Dr. Humaira Syed is a triple board certified ankle and foot surgeon.

Key Points: 
  • SCOTCH PLAINS, N.J., Oct. 29, 2021 /PRNewswire-PRWeb/ -- Dr. Humaira Syed is a triple board certified ankle and foot surgeon.
  • Triple Board certified by American Board of Foot and Ankle Surgery, American Board of Podiatric Medicine, and American Board of Lower Extremity Surgery.
  • Dr. Syed is an active member of the American College of Foot and Ankle Surgeons, American Podiatric Medical Association and the New Jersey Podiatric Medical Society.
  • Dr. Humaira Syed, of Reds Ankle and Foot Associates is committed to getting every patient back on their feet faster.

Alex Tievsky, DPM is recognized by Continental Who's Who

Retrieved on: 
Monday, August 30, 2021
Certification, Continental, Hunter College, Bunion, Medicine, Wart, American Board of Commissioners for Foreign Missions, Trauma, Diabetes, New York College of Podiatric Medicine, Achilles tendinitis, Wound healing, Multimedia, Hospital, Bachelor, FAIR, Patient, Long Island, Surgery, Peripheral neuropathy, DPM, National Intrepid Center of Excellence, Dentistry

FAIR LAWN, N.J., Aug. 30, 2021 /PRNewswire/ --Alex Tievsky, DPM, is being recognized by Continental Who's Who as a Trusted Name in Podiatry for his excellent work in the Medical field and in recognition of his work at Tievsky Podiatry LLC.

Key Points: 
  • FAIR LAWN, N.J., Aug. 30, 2021 /PRNewswire/ --Alex Tievsky, DPM, is being recognized by Continental Who's Who as a Trusted Name in Podiatry for his excellent work in the Medical field and in recognition of his work at Tievsky Podiatry LLC.
  • Alex Tievsky is being recognized for his seven years of exceptional work in the medical field at his two private practices in New Jersey and New York.
  • Throughout his years of practice, he has become renowned as one of the country's top surgeons for minimally invasive collapsed arches surgeries.
  • Dr. Tievsky knew from a young age that he wanted to go into the Medical profession.